NCT06214130View on ClinicalTrials.gov

Bioavailability of Orfiril Long 500 mg Prolonged-Release Minitablets and Ergenyl Chrono 500 mg Prolonged-Release Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

September 22, 2023

Primary Completion Date

November 6, 2023

Study Completion Date

November 18, 2023

Conditions
Multiple Drug Use
Interventions
DRUG

Sodium valproate 500 MG

oral intake

DRUG

Valproic Acid 500 MG

oral intake

Trial Locations (1)

M9L 3A2

Biopharma Services INC, Toronto

Sponsors

Collaborators (1)

BioPharma Services Inc.
All Listed Sponsors
collaborator

BioPharma Services Inc.

INDUSTRY

lead

Desitin Arzneimittel GmbH

INDUSTRY